Patient-reported Outcomes and Burden of Disease in Paediatric Patients with Psoriasis: Real-world Data from EU5 and US
Acta Derm Venereol
.
2023 Apr 19:103:adv2544.
doi: 10.2340/actadv.v103.2544.
Authors
Marieke M B Seyger
1
,
Amy Paller
2
,
Michael Sticherling
3
,
Teresa Bachhuber
4
,
Nicolas Thomas
4
,
James Hetherington
5
,
James Lucas
5
,
Craig Richardson
4
,
Matthias Augustin
6
Affiliations
1
Department of Dermatology, Radboud University Nijmegen Medical Centre, NL-6500 HB Nijmegen, the Netherlands.
[email protected]
.
2
Departments of Dermatology and Paediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
3
Department of Dermatology, Universitaetsklinikum Erlangen, Deutsches Zentrum Immuntherapie Erlangen, Germany.
4
Novartis Pharma AG, Basel, Switzerland.
5
Adelphi Real World, Bollington, UK.
6
Institute for Health Services Research in Dermatology and Nursing, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
PMID:
37073960
PMCID:
PMC10128148
DOI:
10.2340/actadv.v103.2544
No abstract available
MeSH terms
Child
Cost of Illness
Humans
Patient Reported Outcome Measures
Psoriasis* / diagnosis
Psoriasis* / drug therapy
Psoriasis* / epidemiology
Severity of Illness Index